INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

VICTORY CAPITAL MANAGEMENT INC's Holding History (CIK: 0001040188)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 11,938 Value ($000) $1,575 Avg Close — Range —
Q4 2024
Shares 62,199 Value ($000) $5,195 Avg Close — Range —
Q3 2024
Shares 63,742 Value ($000) $4,664 Avg Close — Range —
Q2 2024
Shares 68,139 Value ($000) $4,667 Avg Close — Range —
Q1 2024
Shares 63,465 Value ($000) $4,392 Avg Close — Range —
Q4 2023
Shares 65,956 Value ($000) $4,724 Avg Close — Range —
Q3 2023
Shares 67,479 Value ($000) $3,515 Avg Close — Range —
Q2 2023
Shares 68,297 Value ($000) $4,325 Avg Close — Range —
Q1 2023
Shares 69,531 Value ($000) $3,765 Avg Close — Range —
Q4 2022
Shares 107,880 Value ($000) $5,709 Avg Close — Range —
Q3 2022
Shares 295,395 Value ($000) $13,745 Avg Close — Range —
Q2 2022
Shares 1,134,850 Value ($000) $64,777 Avg Close — Range —
Q1 2022
Shares 932,322 Value ($000) $56,901 Avg Close — Range —